Aegis Sciences Corporation today announced the successful completion of a $170 million debt refinancing...
Aegis Sciences Corporation is pleased to announce an updated testing menu which will include new novel psychoactive...
Aegis is excited to announce that we are offering PCR testing for oropouche virus infection as a result of...
Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
Medetomidine is a non-opioid veterinary anesthetic that acts as a synthetic agonist at alpha-2-adrenergic receptors. It belongs to the same...
Aegis has been selected by the Centers for Disease Control and Prevention (CDC)...
Sign up for the Aegis Newsletter